Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs for Steroid-Resistant aGVHD
NCT04738981Phase 3Completed
- Sponsor
- Peking University People's Hospital
- Start
- Feb 2021
- Primary completion
- May 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of human umbilical cord mesenchymal stem cells in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Peking University People's Hospital. Started Feb 2021; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT04738981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04738981.